NEW YORK – Meridian Bioscience said on Wednesday that it has received approximately $1 million in funding from the National Institute of Health's Rapid Acceleration of Diagnostics program to expedite the launch of its SARS-CoV-2 PCR test.
NEW YORK – Meridian Bioscience said on Wednesday that it has received approximately $1 million in funding from the National Institute of Health's Rapid Acceleration of Diagnostics program to expedite the launch of its SARS-CoV-2 PCR test.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.